Related references
Note: Only part of the references are listed.Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities
Heng Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
DJ-1 protein regulates CD3+T cell migration via overexpression of CXCR4 receptor
Seung Hyo Jung et al.
ATHEROSCLEROSIS (2014)
Small molecule Me6TREN mobilizes hematopoietic stem/progenitor cells by activating MMP-9 expression and disrupting SDF-1/CXCR4 axis
Jing Zhang et al.
BLOOD (2014)
Gambogic acid inhibits multiple myeloma mediated osteoclastogenesis through suppression of chemokine receptor CXCR4 signaling pathways
Manoj K. Pandey et al.
EXPERIMENTAL HEMATOLOGY (2014)
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
Francoise Bachelerie et al.
PHARMACOLOGICAL REVIEWS (2014)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Effective inhibition of metastases and primary tumor growth with CTCE-9908 in esophageal cancer
Astrid Drenckhan et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Distinct CCK-2 Receptor Conformations Associated with β-Arrestin-2 Recruitment or Phospholipase-C Activation Revealed by a Biased Antagonist
Remi Magnan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Small Molecule Inhibitors of CXCR4
Bikash Debnath et al.
THERANOSTICS (2013)
The molecular pharmacology of AMD11070: An orally bioavailable CXCR4 HIV entry inhibitor
Renee M. Mosi et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Cardiorenal Actions of TRV120027, a Novel β-Arrestin-Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines A Novel Therapeutic Strategy for Acute Heart Failure
Guido Boerrigter et al.
CIRCULATION-HEART FAILURE (2011)
Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists
Sameer P. Kawatkar et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Chemokines in health and disease
Dayanidhi Raman et al.
EXPERIMENTAL CELL RESEARCH (2011)
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS
Stephanie Gravel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
Effects of CXCR4 Antagonist CTCE-9908 on Prostate Tumor Growth
Stacy Porvasnik et al.
PROSTATE (2009)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo
Gebhard Thoma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases
Su Young Kim et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Discovery of small molecule CXCR4 antagonists
Weiqiang Zhan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects
Nimalie D. Stone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Regulation of CXCR4 signaling
John M. Busillo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
The many facets of SDF-1 alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells
Anne Faber et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2007)
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
S Hatse et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells
N Flomenberg et al.
ACTA HAEMATOLOGICA (2005)
Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies
S Hatse et al.
CYTOMETRY PART A (2004)
CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro
K Vermeire et al.
AIDS (2004)
The significance of cancer cell expression of the chemokine receptor CXCR4
F Balkwill
SEMINARS IN CANCER BIOLOGY (2004)
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro
J Juarez et al.
LEUKEMIA (2003)
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
PA Hernandez et al.
NATURE GENETICS (2003)
Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140
H Tamamura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium
T Nanki et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
